Voltage-Gated Ion Channels as Drug Targets

Author:   David J. Triggle (State University of New York, Buffalo, USA) ,  Murali Gopalakrishnan (Abbott Laboratories, Abbott Park, USA) ,  David Rampe (Aventis Pharmaceuticals, Bridgewater, USA) ,  Wei Zheng (Merck & Co., North Wales, USA)
Publisher:   Wiley-VCH Verlag GmbH
ISBN:  

9783527312580


Pages:   492
Publication Date:   17 February 2006
Format:   Hardback
Availability:   Out of stock   Availability explained


Our Price $630.96 Quantity:  
Add to Cart

Share |

Voltage-Gated Ion Channels as Drug Targets


Overview

Full Product Details

Author:   David J. Triggle (State University of New York, Buffalo, USA) ,  Murali Gopalakrishnan (Abbott Laboratories, Abbott Park, USA) ,  David Rampe (Aventis Pharmaceuticals, Bridgewater, USA) ,  Wei Zheng (Merck & Co., North Wales, USA)
Publisher:   Wiley-VCH Verlag GmbH
Imprint:   Blackwell Verlag GmbH
Dimensions:   Width: 17.50cm , Height: 2.80cm , Length: 24.40cm
Weight:   1.066kg
ISBN:  

9783527312580


ISBN 10:   3527312587
Pages:   492
Publication Date:   17 February 2006
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Out of Print
Availability:   Out of stock   Availability explained

Table of Contents

Reviews

...this volume should be of interest to a broad range of medicinal chemists and pharmacologists. (Journal of Medicinial Chemistry, August 24, 2006)


Author Information

David J. Triggle is a Professor for Pharmacy at the State University of New York at Buffalo, USA, where he is investigating drug-receptor interactions and has specialized in ion channel pharmacology. He is the author of several books, has contributed around 350 papers, chapters and reviews, and has presented over 1,000 lectures worldwide. David Rampe is currently head of the Safety Pharmacology Department at Sanofi-Aventis Pharmaceuticals in Bridgewater, NJ, USA. Over the past 17 years he has worked in both the discovery and development areas of the pharmaceutical industry. Wei Zheng is a Group Leader at the NIH Chemical Genomics Center. He was previously a Group Leader at Merck's centralized screening center. Over the past 12 years he has being working in the area of assay development and high throughput screening. Murali Gopalakrishnan is a Project Leader in the Neuroscience Research Division of Abbott Laboratories, Illinois, USA. Over the past 12 years he has been engaged in various drug discovery programs in the areas of central nervous system, urology and pain.

Tab Content 6

Author Website:  

Countries Available

All regions
Latest Reading Guide

NOV RG 20252

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List